All News

With many targeted treatment options for patients with CLL to use upfront, the question arises as to which one is best for the individual.

For my well-being, I am finding a pineapple a day may help in keeping the doctor away.

A brief, multimodal psychosocial intervention for caregivers of patients undergoing hematopoietic stem cell transplantation could improve their quality of life, caregiving burden and anxiety and depression symptoms.

In a first-of-its-kind study, researchers have found an increase in alcohol consumption among cancer survivors that warrants further study and possible alcohol consumption screenings prior to treatment.

The Bladder Cancer Advocacy Network announces it's Bladder Cancer Research Innovation Award.

Researchers from Roswell Park Comprehensive Cancer Center found that the use of supplements, besides a multivitamin, while patients were being treated with chemotherapy increased their risk for breast cancer recurrence or death.

Patients with cancer are acutely aware of how time is finite, and that's ok. They can appreciate the fit of time all the better.

Despite differences in tumors, the addition of CDK 4/6 inhibitors to endocrine therapy showed a benefit in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer compared with endocrine therapy alone.

The three-drug combination of Perjeta and Herceptin with Gemzar shows improved progression-free survival in patients with metastatic breast cancer to advance to a phase 3 trial.

Findings from a recent study supported further evaluation of comparing anti–PD-1 to anti–PD-L1 therapy to help determine treatment options for patients with cancer.

A male breast cancer survivor's take on some promising statistics that show a decline in the cancer death rate in the US, but not for every type of cancer.

FDA has given an accelerated approval to Padcev in the treatment of patients with locally advanced or metastatic urothelial cancer.

Personalized treatments have changed the cancer landscape, and continue to change it for patients with renal cell carcinoma.

One breast cancer and melanoma survivor thinks about the long-term impacts of her cancer diagnosis and the silver linings.

Patients with gastrointestinal stromal tumors have a new targeted therapy that looks to tackle secondary mutations after it showed a strong response rate in the clinic.

Cancer mortality rates have declined significantly since 1991; however, certain cancer types have seen slower progression as of recently because of improved screening.

Researchers found that those who experienced a potentially burdensome end-of-life transition, were more likely not to receive hospice care.

The medication plinabulin is currently being tested in clinical trials to see its benefits in treating chemotherapy-induced neutropenia.

The Bladder Cancer Advocacy Network (BCAN) is pleased to announce two 2020 Young Investigator Awards (YIA), to support the development of outstanding early-career research scientists and clinical cancer research investigators.

This new option may save patients with high-risk non-muscle invasive bladder cancer from having to undergo a radical cystectomy to treat their disease.

Finally, I'm experiencing a little less worry on my cancer journey and gaining some freedom from cancer.

A recent study has found that real acupuncture can not only reduce a patient's cancer pain from various types of cancer, but also reduce their painkiller use.

At 15 years old the Bladder Cancer Advocacy Network looks back and takes a look ahead.

From the largest one-year cancer death rate drop in the US to Supreme Court Justice Ruth Bader Ginsburg announcing she is cancer-free for a fourth time, here’s what is making the headlines in the cancer space this week.

The Food and Drug Administration approved Ayvakit for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumor who exhibited a platelet-derived growth factor receptor alpha exon 18 mutation.

Increasing doses, cutting pills and self-tapering of opioids can lead to safety risks for patients with cancer; however, this is an issue that often goes unaddressed.

Cancer survivors need to keep up with the news. However, reading about a new study or risk factor might make us worry about past choices and/or current options, in a way we can't quite control.

In a new study, researchers set out to prove whether or not there was a statistically significant risk of ovarian cancer from the use of talc-based powder.